FRANCISCO JAVIER
CAPOTE HUELVA
Profesor asociado de Ciencias de la Salud
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (4)
2019
-
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966
2013
-
Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)
Medical Mycology, Vol. 51, Núm. 2, pp. 150-154
2007
-
Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease
Haematologica, Vol. 92, Núm. 11, pp. 1489-1494
2004
-
HIV-2 and HTLV-I/II infections in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182